Oregano

When observing the behavior of carvacrol in various chronic diseases, it becomes clear that this compound does not act on individual symptoms, but rather intervenes in common pathophysiological mechanisms, particularly chronic inflammation, oxidative stress, metabolic dysfunction, and alterations in cell survival signaling. It is precisely this cross-cutting action that makes oregano a spice of particular interest in the context of metabolic and immune medicine.

In diabetes mellitus, carvacrol has established itself as a promising molecule due to its ability to improve glycemic control through multiple levels of regulation. Experimental evidence shows that carvacrol reduces glycemia both by acting on the intestinal absorption of carbohydrates, through the inhibition of digestive enzymes, and by improving insulin sensitivity in peripheral tissues through increased expression of GLUT-4 transporters (Hoca et al., 2024) [6]. At the same time, carvacrol reduces oxidative stress and the production of pro-inflammatory cytokines, two factors that fuel insulin resistance over time. In this sense, its effect is not to "force" glycemia downward, but to lighten the metabolic load that forces the body to maintain chronically high levels of insulin.

This ability to modulate inflammation and oxidative response also becomes particularly evident in the context of asthma, a chronic inflammatory disease of the airways in which oxidative stress, bronchial hyperreactivity, and cytokine imbalance reinforce each other. Carvacrol has been shown to reduce mucus production and bronchial resistance in experimental models of asthma, acting through the inhibition of key inflammatory mediators such as IL-4, IL-5, IL-13, and TNF-α (Neopane and Kushwaha, 2025) [7]. Added to these effects is a moderate bronchodilator action, mediated by the inhibition of calcium channels and the release of nitric oxide, which contributes to improving respiratory function. It is as if carvacrol simultaneously reduces underlying inflammation and excessive airway reactivity, acting on both the cause and the consequences of the pathological process.

Another area where carvacrol shows a particularly solid action is that of gastrointestinal diseases, starting with gastric ulcers. In models of induced ulcers, carvacrol has demonstrated marked gastroprotective activity, reducing the extent of lesions, preserving the mucosal barrier, and normalizing acid secretion (Badr et al., 2023) [8]. This effect is mediated by a reduction in the production of reactive oxygen species and the suppression of inflammatory mediators. In parallel, from a functional point of view, it is as if carvacrol simultaneously reinforces the stomach's defensive "walls" and extinguishes the oxidative fire that undermines its integrity.

The role of carvacrol becomes even more articulated when moving to neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. In these contexts, oxidative stress and neuroinflammation represent true drivers of progressive neurodegeneration. Preclinical evidence indicates that carvacrol improves cognitive and motor functions, lowers levels of pro-inflammatory cytokines, and protects neurons (Javed et al., 2023) [9]. Particularly relevant is carvacrol's ability to cross the blood-brain barrier and act directly on the neuronal microenvironment, creating conditions more favorable to survival and synaptic plasticity. In this sense, carvacrol does not merely slow down damage, but contributes to improving the resilience of nervous tissue.

A separate chapter concerns the potential of carvacrol in the oncological context, particularly in gastrointestinal cancers. Preclinical evidence shows that carvacrol reduces tumor proliferation, induces cell cycle arrest and apoptosis, inhibits angiogenesis, and limits invasion and metastasis processes in models of gastric, pancreatic, hepatic, and colorectal carcinoma. It is significant to note that carvacrol shows greater selectivity toward tumor cells compared to healthy ones, suggesting a potential role as a therapeutic adjuvant rather than an indiscriminate cytotoxic agent. The nano-formulation strategies described in the most recent studies aim precisely to improve bioavailability and targeting, making the transition from preclinical research to clinical application more realistic (Patwa et al., 2025) [10].

Taken together, this evidence outlines carvacrol as a multi-target biological modulator, capable of intervening in seemingly different diseases that are united by a common foundation of chronic inflammation, oxidative stress, and metabolic dysregulation. Included in a lifestyle oriented toward glycemic stability, the reduction of hyperinsulinemia, and the containment of low-grade inflammation, oregano does not act as an isolated remedy, but as a spice capable of supporting and strengthening the physiological rebalancing processes that the body struggles to maintain in the modern context.

One of the most interesting aspects of oregano concerns its ability to intervene directly in the biological mechanisms underlying insulin resistance, a condition that represents one of the main pathophysiological drivers of type 2 diabetes, non-alcoholic fatty liver disease, and metabolic syndrome. In the presence of insulin resistance, peripheral tissues progressively lose the ability to respond correctly to insulin signaling, forcing the pancreas to produce increasing amounts of insulin to maintain stable glycemia. This state of chronic hyperinsulinemia fuels systemic inflammation, oxidative stress, lipid accumulation, and continuous activation of the PI3K/AKT/mTOR pathway.

In this context, carvacrol, the main bioactive compound in oregano, appears to act as a multifactorial metabolic modulator. One of the most interesting pieces of evidence emerges from studies on diabetic liver damage in "db/db" mice, an experimental model of type 2 diabetes strongly characterized by insulin resistance, steatosis, and chronic inflammation. Treatment with carvacrol resulted in a significant reduction in glycemia and a clear improvement in insulin resistance, accompanied by normalization of the lipid profile and attenuation of liver damage. In parallel, an increase in the expression of INSR, IRS1, and their respective phosphorylated forms was observed, suggesting a functional recovery of hepatic insulin signaling (Zhao et al., 2021) [11].

This step is particularly important because it shows that carvacrol does not simply act by "lowering sugar," but by improving the liver's ability to respond physiologically to insulin. In other words, the liver tissue progressively returns to recognizing the insulin signal without requiring continuous compensatory hypersecretion. The study also highlighted a reduction in the pathological phosphorylation of AKT1 and mTOR, confirming the profound link between insulin resistance and chronic hyperactivation of the insulin pathway.

A particularly interesting aspect concerns the role of chronic inflammation. In diabetic mice treated with carvacrol, a significant reduction in the activation of NF-κB was observed, one of the main mediators of metabolic inflammation associated with insulin resistance. This finding is relevant because low-grade chronic inflammation is one of the mechanisms that keep the insulin response in peripheral tissues constantly altered (Zhao et al., 2021) [11].

The relationship between oregano and insulin sensitivity also emerges with great clarity in studies on human adipocytes exposed to palmitic acid, one of the main saturated fatty acids involved in the onset of insulin resistance associated with obesity. In this experimental model, the essential oil of Origanum vulgare significantly attenuated the insulin signaling alterations induced by palmitic acid, improving the phosphorylation of IRS-1, AKT, and AS160 (a key protein in human metabolism) and increasing cellular glucose uptake (Müller et al., 2025) [12].

From a biological point of view, this means that the bioactive compounds in oregano help the adipose cell to "reopen" the PI3K/AKT pathway compromised by lipid excess and oxidative stress. The improvement in AS160 phosphorylation is particularly important because this protein represents one of the main regulators of GLUT4 translocation to the cell membrane. In other words, oregano appears to promote the correct entry of glucose into the cell, improving peripheral insulin sensitivity.

The study also highlighted that oregano essential oil possesses high antioxidant activity and a significant phenolic content (Müller et al., 2025) [12]. This aspect is particularly relevant because oxidative stress is one of the main factors responsible for insulin signaling dysfunction. Excessive production of reactive oxygen species indeed alters IRS-1, compromises the PI3K/AKT pathway, and promotes a persistent inflammatory state that further fuels insulin resistance.

The most recent reviews on the molecular mechanisms of carvacrol in diabetes also confirm this picture. A review dedicated to the phenolic monoterpenes of oregano and thyme highlights that carvacrol and thymol improve insulin sensitivity through the modulation of the PI3K/AKT and AMPK pathways, increasing GLUT4 translocation and promoting peripheral glucose absorption. The authors also emphasize that these compounds reduce inflammation and oxidative stress through the inhibition of NF-κB and the reduction of TNF-α and IL-6 (Ali and Mishra, 2026) [13].

This step is extremely important because it shows how insulin resistance is not simply a "glucose disease," but a systemic condition in which energy metabolism, inflammation, and oxidative stress are deeply intertwined. Carvacrol appears to intervene simultaneously at all these levels, helping to break the vicious cycle that keeps cellular metabolism constantly altered.

The review also highlights a possible synergy between carvacrol and metformin. This finding is particularly relevant because metformin is one of the main drugs used in the treatment of insulin resistance precisely due to its ability to activate AMPK and improve peripheral glucose uptake. The fact that carvacrol shares some of these mechanisms further strengthens the biological plausibility of its metabolic effects (Ali and Mishra, 2026) [13].

Overall, the available evidence shows that oregano does not act simply as an aromatic spice or a generic antioxidant, but as a true modulator of metabolic physiology. Through carvacrol and other bioactive phenolic compounds, oregano appears to improve insulin sensitivity, peripheral glucose uptake, lipid metabolism, chronic inflammation, and oxidative stress.

In this sense, the relationship between oregano and insulin resistance represents one of the most interesting examples of how a natural compound can interact with the main biological nodes of modern metabolic diseases, helping to reduce the burden imposed by chronic hyperinsulinemia and the continuous activation of the insulin pathway.

To understand the profound role of oregano in the context of modern chronic diseases, it is necessary to focus on the relationship between its main bioactive compound, carvacrol, and the PI3K–AKT–mTOR insulin pathway, one of the central nodes connecting nutrition, metabolism, inflammation, and cell proliferation. mTOR represents the biological sensor of abundance: when nutrients, insulin, and growth signals are constantly elevated, this pathway remains chronically active, promoting disordered growth, reduced autophagy, and a loss of metabolic flexibility. It is precisely this condition of persistent hyperactivation that constitutes the common ground for many metabolic, inflammatory, and tumor-related diseases.

In this scenario, carvacrol emerges as a natural modulator of mTOR, capable of reducing its pathological activation without completely shutting down its physiological function. An in-depth review of solid carcinomas shows how carvacrol consistently interferes with major oncogenic pathways, particularly PI3K/AKT/mTOR, helping to reduce the proliferation, angiogenesis, and metastatic capacity of tumor cells. The inhibition of mTOR is accompanied by the activation of programmed cell death mechanisms and the reactivation of autophagy, processes that are normally blocked when the growth signal remains constantly switched on (Ahmad et al., 2021) [14].

This multi-level action is further confirmed by a systematic review that analyzes carvacrol as a regulator of various molecular targets in cancer. In this work, carvacrol is described as a molecule capable of modulating the PI3K/AKT/mTOR pathway, showing particular efficacy in reducing cell survival and promoting cell cycle arrest (Singh et al., 2023) [15]. It is significant that this modulation occurs through a controlled increase in intracellular oxidative stress in pathological cells, rendering them vulnerable precisely because they are dependent on mTOR for their survival.

The direct link between carvacrol and mTOR has also been explored through in silico approaches (conducting studies, analyses, or simulations via computer using mathematical models and algorithms), which allow for the observation of molecule-target interaction at the atomic level. In a molecular dynamics study, carvacrol showed a binding affinity for mTOR comparable to that of rapamycin, the best-known pharmacological inhibitor of this pathway (Herrera-Calderon et al., 2020) [16]. The simulations highlighted a stable and lasting interaction with the catalytic site of mTOR, suggesting that this pathway represents one of the main mediators of the biological effects observed in vivo. From a conceptual standpoint, this finding is extremely relevant: it indicates that carvacrol does not act only "upstream" by reducing inflammatory or insulin signals, but can interact directly with the command center of cell growth.

The modulation of mTOR by carvacrol is not limited to oncology but also extends to non-neoplastic chronic inflammatory diseases. A particularly emblematic example is endometriosis, a condition characterized by persistent inflammation, oxidative stress, and dysregulation of cell survival pathways. In murine and cellular models of endometriosis, carvacrol significantly reduced lesion size, modulated calcium homeostasis, inhibited the PI3K pathway, and promoted autophagy, helping to restore a balance between proliferation and cellular recycling (Jang et al., 2025) [17]. This finding is particularly interesting because it shows how the functional inhibition of mTOR can be useful not only for eliminating tumor cells but also for reducing the survival of pathological ectopic tissues.

Further confirmation of the central role of the PI3K/AKT/mTOR pathway comes from studies on breast cancer. In the observed cells, carvacrol induced cell cycle arrest and promoted apoptosis through the suppression of PI3K and AKT phosphorylation, events that precede and determine the reduction of mTOR activity (Mari et al., 2021) [18]. This study indicates that carvacrol forces the tumor cell to exit the forced growth mode, reactivating control and programmed death programs.

Taken together, these studies outline an extremely coherent picture: carvacrol acts as a metabolic and proliferative regulator of mTOR, capable of reducing the pathological hyperactivation of the pathway, reactivating autophagy, and limiting the survival of cells that depend on a constant growth signal. This behavior is particularly relevant in the modern context, characterized by chronic hyperinsulinemia, nutritional excess, and low-grade inflammation, conditions that keep mTOR permanently switched on.

In this sense, oregano cannot be interpreted as a simple antioxidant or anti-inflammatory spice, but as a metabolically intelligent plant capable of communicating with one of the most central nodes of human pathophysiology. Included within a lifestyle oriented toward glycemic stability, the reduction of hyperinsulinemia, and the containment of chronic inflammation, carvacrol helps shift the body from a mode of disordered growth toward a mode of balance, adaptation, and cellular maintenance.

If the relationship between carvacrol and mTOR already shows significant metabolic and proliferative relevance, the picture becomes even more interesting when observing the role of AMPK, the primary cellular energy sensor. As discussed in previous chapters, AMPK and mTOR represent two physiologically complementary systems: when nutrients, glucose, and insulin are abundant, mTOR promotes cell growth, protein synthesis, and energy storage; conversely, when the cell perceives a state of metabolic stress or reduced energy availability, AMPK reduces anabolic processes, reactivates autophagy, and promotes the restoration of cellular homeostasis. In this delicate balance, carvacrol appears to act as a modulator capable of restoring the proper dialogue between these two pathways.

One of the clearest examples emerges from studies on hepatic steatosis induced by a high-fat diet. In mouse models fed a high-lipid diet, carvacrol significantly reduced hepatic lipid accumulation, improved markers of liver damage, and attenuated systemic inflammation by enhancing the pathway involving AMPK. In parallel, a reduction in the expression of lipogenic genes was observed, accompanied by an increase in genes involved in fatty acid oxidation (Kim et al., 2013) [19].

This step is particularly important because it shows how carvacrol does not simply act as a generic antioxidant, but intervenes directly in the metabolic programs that regulate lipid accumulation and utilization. From a pathophysiological perspective, hepatic steatosis represents one of the main consequences of chronic hyperinsulinemia and mTOR overactivation: when the insulin signal remains constantly elevated, the liver is pushed toward continuous lipogenesis and triglyceride accumulation. The activation of AMPK by carvacrol, on the other hand, represents an opposing metabolic signal that favors lipid oxidation, energy conservation, and improved metabolic flexibility (Kim et al., 2013) [19].

Also particularly interesting is the link between AMPK and inflammation. In mice treated with carvacrol, a significant reduction in the activation of TLR2/4-dependent pathways (sentinels of our innate immune system) and the inflammatory cytokine TNF-α was observed. This finding carries deep significance because low-grade chronic inflammation is one of the main factors that keep mTOR constantly active in modern metabolic diseases. Through the modulation of AMPK, carvacrol thus appears to help interrupt one of the main self-reinforcing circuits of insulin resistance and metabolic dysfunction.

This ability to simultaneously regulate AMPK, glucose metabolism, and oxidative stress also emerges in recent reviews on the role of carvacrol in type 2 diabetes. A review dedicated to the molecular mechanisms of carvacrol and thymol highlights that these phenolic monoterpenes improve insulin sensitivity, increase peripheral glucose uptake, and reduce oxidative stress precisely through the modulation of the PI3K/AKT, AMPK, and NF-κB pathways (Ali and Mishra, 2026) [13].

The authors emphasize that AMPK activation increases fatty acid oxidation, reduces hepatic gluconeogenesis, and improves cellular energy metabolism. This aspect is extremely relevant because it directly connects the metabolic effects of oregano with the insulin pathway discussed in previous chapters. Indeed, when AMPK is activated, the cell progressively reduces its "permanent anabolic state," limiting the chronic mTOR overactivation typical of persistent hyperinsulinemia.

The review also highlights that carvacrol exerts significant anti-inflammatory activity through the inhibition of the NF-κB pathway and the reduction of TNF-α and IL-6. From a biological standpoint, this means that carvacrol does not act on a single target, but simultaneously modulates energy metabolism, inflammation, and oxidative stress—all elements deeply intertwined in the pathophysiology of insulin resistance and chronic metabolic diseases.

A particularly interesting aspect concerns the possible synergy with metformin: the authors point out that carvacrol and metformin share, at least in part, the activation of the AMPK pathway. This is very important because metformin is one of the main drugs used in the treatment of insulin resistance and type 2 diabetes precisely due to its ability to activate AMPK and reduce hepatic glucose production. The fact that a natural compound like carvacrol can interact with the same pathway further reinforces the biological coherence of its metabolic effects (Ali and Mishra, 2026) [13].

Overall, the available evidence outlines carvacrol as an extremely sophisticated energy modulator. Through the activation of AMPK and the reduction of pathological mTOR overactivation, oregano appears to promote autophagy, lipid oxidation, reduction of lipogenesis, improvement of insulin sensitivity, and control of chronic inflammation.

In a context characterized by persistent caloric excess, chronic hyperinsulinemia, and continuous anabolic stimulation, the relationship between oregano, AMPK, and mTOR thus takes on a meaning deeply consistent with what was discussed in previous chapters: helping the cell exit a mode of forced growth and metabolic dysfunction, returning it toward a condition of greater adaptation, maintenance, and energy flexibility.